Irritable Bowel Syndrome

GI Epidemiology

Volumn , Issue , 2008, Pages 176-183

  Saito, Yuri A ^a   Talley, Nicholas J ^a,b   Locke, G Richard ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antidirrheals; Bowel syndrome; Chronic disorder; Gastrointestinal dysmotility; Neuromodulators

Indexed keywords

EID: 58649111226     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470692189.ch24     Document Type: Chapter

References (70)

1. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease. Lancet 2002;360:555.
2. Longstreth GF et al. Functional bowel disorders. Gastroenterology 2006;130:1480.
3. Manning AP et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;ii:653.
4. Thompson WG et al. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterology International 1989;2:92.
5. Drossman DA et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International 1990;3:159.
6. Thompson WG et al. Functional bowel disease and functional abdominal pain. Gastroenterology International 1992;5:75.
7. Thompson WG et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl. 2):II43.
8. Lea R et al. Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice. Digestion 2004;70:210.
9. Charapata C, Mertz H. Physician knowledge of Rome symptom criteria for irritable bowel syndrome is poor among nongastroenterologists. Neurogastroenterol Motil 2006;18:211.
10. Longstreth GF, Burchette RJ. Family practitioners' attitudes and knowledge about irritable bowel syndrome: effect of a trial of physician education. Fam Pract 2003;20:670.
11. Vandvik PO et al. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria. Scand J Gastroenterol 2004;39:448.
12. Saito YA et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2816.
13. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409.
14. Drossman DA et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569.
15. Talley NJ et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927.
16. Talley NJ et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165.
17. Locke GR 3rd et al. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther 2004;19:1025.
18. Garcia Rodriguez LA et al. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000;35:306.
19. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005;34:189.
20. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005;21:663.
21. Wigington WC et al. Epidemiology of irritable bowel syndrome among African Americans as compared with whites: a population-based study. Clin Gastroenterol Hepato panics and non-Hispanic whites. Dig Dis Sci 1995;40:1763.
22. Zuckerman MJ et al. Comparison of bowel patterns in His panics and non-Hispanic whites. Dig Dis Sci 1995;40:1763.
23. Zuckerman MJ et al. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci 1996;41:77.
24. Lea R, Whorwell PJ. The role of food intolerance in irritable bowel syndrome. Gastroenterol Clin North Am 2005;34:247.
25. Saito YA et al. Diet and functional gastrointestinal disorders: a population based case-control study. Am J Gastroenterol 2003;98:S275.
26. Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 2005;128:1089.
27. Palsson OS, Drossman DA. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005;34:281.
28. Kay L et al. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23.
29. Weinryb RM et al. Psychological factors in irritable bowel syndrome: a population-based study of patients, non-patients and controls. Scand J Gastroenterol 2003;38:503.
30. Kanazawa M et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci 2004;49:1046.
31. Talley NJ et al. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997;41:394.
32. Walker EA et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993;150:1502.
33. Delvaux, M et al. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol 1997;9:345.
34. Talley NJ et al. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol 1995;90:366.
35. Hobbis IC et al. A re-examination of the relationship between abuse experience and functional bowel disorders. Scand J Gastroenterol 2002;37:423.
36. Baccini F et al. Prevalence of sexual and physical abuse and its relationship with symptom manifestations in patients with chronic organic and functional gastrointestinal disorders. Dig Liver Dis 2003;35:256.
37. Talley NJ et al. Gastrointestinal tract symptoms and selfreported abuse: a population-based study. Gastroenterology 1994;107:1040.
38. Talley NJ et al. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998;42:47.
39. Gwee KA et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996;347:150.
40. Gwee KA et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400.
41. Neal KR et al. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 1997;314:779.
42. Urfer E et al. Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: clinical and molecular epidemiology. Clin Microbiol Infect 2000;6:536.
43. Thornley JP et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001;184:606.
44. Cumberland P et al. The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode. Epidemiol Infect 2003;130:453.
45. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Br Med J 1999;318:565.
46. Parry SD et al. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 2003;98:327.
47. Parry SD et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003;98:1970.
48. Marshall JK et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445; quiz 660.
49. Whorwell PJ et al. Non-colonic features of irritable bowel syndrome. Gut 1986;27:37.
50. Bellentani S et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 1990;7:307.
51. Levy RL et al. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000;95:451.
52. Locke GR 3rd et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000;75:907.
53. El-Serag HB et al. Systemic review: Natural history of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:861.
54. Mearin F et al. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Aliment Pharmacol Ther 2006;23:815.
55. Agreus L et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905.
56. Maxion-Bergemann S et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21.
57. Silk DB. Impact of irritable bowel syndrome on personal relationships and working practices. Eur J Gastroenterol Hepatol 2001;13:1327.
58. Dapoigny M et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 2004;16:995.
59. Hungin AP et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365.
60. El-Serag HB et al. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171.
61. Sandler RS et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500.
62. Kozma CM et al. A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. Manag Care Interface 2002;15:40,49.
63. Levy RL et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122.
64. Patel RP et al. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 2002;35:14.
65. Longstreth GF et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003;98:600.
66. Leong SA et al. The economic consequences of irritable bowel syndrome: a US employer perspective. Arch Intern Med 2003;163:929.
67. Martin BC et al. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin 2003;19:771.
68. Talley NJ et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895.
69. Hahn et al. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997;42:2585.
70. Saito YA et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003;15:687.